Mode
Text Size
Log in / Sign up

ANCA-associated vasculitis associated with higher mortality and cardiovascular events in retrospective cohort analysisNew data links rare blood vessel diseases to higher death and heart risks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the association between ANCA-associated vasculitis and increased mortality and cardiovascular risk in a retrospective cohort.

This retrospective cohort study utilized the US-based TriNetX network electronic health records database to evaluate patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). The population included 20,422 patients with GPA and 5,907 with MPA. These individuals were compared against a matched control cohort without vasculitis using 1:1 propensity score matching.

Primary outcomes included mortality and cardiovascular events. Mortality rates were 17.87% for GPA patients versus 5.79% for controls, with a hazard ratio of 3.01. For MPA patients, mortality was 25.85% compared to 9.70% in controls, also with a hazard ratio of 3.01. MACE risk was increased in GPA with a hazard ratio of 1.94 and in MPA with a hazard ratio of 2.24.

Thromboembolic risks were elevated, including deep vein thrombosis with hazard ratios of 2.82 for GPA and 3.33 for MPA. Pulmonary embolism risks showed hazard ratios of 3.01 for GPA and 3.00 for MPA. Safety data regarding adverse events were not reported in the study. Follow-up duration was not reported.

Key limitations include the observational study design which indicates association rather than causation. Results were based on diagnostic codes in electronic health records. Practice relevance suggests ANCA-associated vasculitis is associated with increased risk of death and cardiovascular events. Clinicians must interpret these findings as associations due to the retrospective nature of the cohort study design.

Imagine finding out your body is fighting a rare blood vessel disease. Now imagine learning that this fight might cost you more than just your energy. A new look at medical records asks a scary question: does having granulomatosis with polyangiitis or microscopic polyangiitis put your life at greater risk?

Researchers pulled data from more than 26,000 patients in the United States. They compared people with these conditions against healthy controls. The results were stark. People with granulomatosis with polyangiitis died at nearly three times the rate of controls. Those with microscopic polyangiitis faced a higher absolute death rate. Heart events and blood clots also appeared much more often in these groups.

Here is the catch. This study did not prove the disease caused these deaths. It simply found a strong connection. The team looked at past records rather than following patients forward in time. They also relied on diagnosis codes written in electronic files. These details matter because they limit what we can conclude about cause and effect.

Still, the signal is clear enough to pay attention to. Patients with these conditions face higher risks of death and cardiovascular trouble. Doctors and patients need to know this association exists. It does not mean every single person will face these outcomes, but the odds shift significantly.

What this means for you:
Rare blood vessel diseases link to higher death and heart risks, but the study shows association, not cause.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Despite significantly improved therapies in recent years, long-term morbidity and mortality in ANCA-associated vasculitis (AAV) remain high. The leading causes of death within the first year after diagnosis are active vasculitis and in subsequent years cardiovascular diseases, malignancies, and infections. Population-based database and cohort analyses suggest an increased risk for major adverse cardiovascular events (MACE) in AAV. This retrospective cohort study analyzed data samples from an electronic health records database of the US-based TriNetX network. Patients with the diagnostic codes granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) and patients without vasculitis as a matched control cohort (1:1) were included. To optimize between-group comparability, propensity score matching was performed for demographic variables and comorbidity. Hazard ratios (HR) for death and cardiovascular outcomes were calculated using univariate Cox regression after analyzing the matched cohort using the Kaplan-Meier method. We identified 20, 422 patients with GPA and 5, 907 with MPA. Mortality was more frequent in patients with GPA (17.87%) and MPA (25.85%) than in matched controls (GPA controls: 5.79%; MPA controls: 9.70%), corresponding to an increased hazard of death in both cohorts (GPA: HR 3.01; MPA: HR 3.01). The risk of cardiovascular events was increased in GPA and MPA compared to matched controls, particularly for MACE (GPA: HR: 1.94, MPA: HR: 2.24) and thromboembolic events (deep vein thrombosis: GPA HR: 2.82, MPA HR: 3.33; pulmonary embolism: GPA HR: 3.01, MPA HR: 3.00) and did not differ when adjusted according to sex, disease duration, and age. Compared with GPA patients, MPA patients had a higher risk of MACE (HR: 1.13) and peripheral arterial disease (HR: 1.17). AAV was associated with an increased risk of death and cardiovascular events. Compared with GPA, MPA was associated with an increased risk for MACE and peripheral arterial disease.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.